Strategic License Agreements - Additional Information (Details) - USD ($)		1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2023	Aug. 31, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
License Agreements Disclosure [Line Items]
Total revenues				$ 0	$ 5,161,000	$ 0	$ 5,442,000
Option and License Agreement
License Agreements Disclosure [Line Items]
License rights excercise expense				0	0	0	0
Option and License Agreement | Gigagen, Inc
License Agreements Disclosure [Line Items]
License rights excercise expense				0	0	430,000	0
Development and regulatory milestones, aggregate amount payable	$ 20,400,000		$ 20,400,000
Sales milestone, aggregate amount payable	$ 11,000,000		$ 11,000,000
Option and License Agreement | Merck Neuromuscular License Agreement
License Agreements Disclosure [Line Items]
Development and regulatory milestones, aggregate amount payable		$ 5,000,000
Total revenues				$ 0	$ 5,000,000	$ 0	$ 5,000,000